TIP60 Inhibitor TH1834 Reduces Breast Cancer Progression in Xenografts in Mice

被引：11
|
作者：
Idrissou, Mouhamed [1 ,2 ]
Judes, Gaelle [1 ,2 ]
Daures, Marine [1 ,2 ]
Sanchez, Anna [1 ,2 ]
El Ouardi, Driss [1 ,2 ]
Besse, Sophie [2 ]
Degoul, Francoise [2 ]
Penault-Llorca, Frederique [2 ,3 ]
Bignon, Yves-Jean [1 ,2 ]
Bernard-Gallon, Dominique [1 ,2 ]
机构：
[1] CBRV, Ctr Jean Perrin, Dept Oncogenet, 28 Pl Henri Dunant, F-63001 Clermont Ferrand, France
[2] INSERM, UMR 1240, Mol Imaging & Theranost Strategies IMOST, Clermont Ferrand, France
[3] Ctr Jean Perrin, Dept Biopathol, Clermont Ferrand, France
来源：
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY | 2019年 / 23卷 / 09期
关键词：
breast cancer; drug targets and development; TIP60; TH1834; xenografts; in vivo animal research;
D O I：
10.1089/omi.2019.0126
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：457 / 459
页数：3
相关论文
共 33 条
  • [21] Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice
    Shirai, Toshiaki
    Revenko, Alexey S.
    Tibbitts, Justin
    Ngo, Anh T. P.
    Mitrugno, Annachiara
    Healy, Laura D.
    Johnson, Jennifer
    Tucker, Erik I.
    Hinds, Monica T.
    Coussens, Lisa M.
    McCarty, Owen J. T.
    Monia, Brett P.
    Gruber, Andras
    BLOOD ADVANCES, 2019, 3 (20) : 3080 - 3091
  • [22] Bortezomib, a Proteasome Inhibitor, Prevents Metastatic Breast Cancer Osteolysis and Reduces Mammary Fat Pad Tumor Growth in Mice
    Jones, M. D.
    Liu, J. C.
    Schoonmaker, J.
    Barthel, T. K.
    Mulay, S.
    Bouxsein, M. L.
    Stein, G. S.
    Mukherjee, S.
    Lian, J. B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S108 - S108
  • [23] The proteasome inhibitor bortezomib reduces mammary fat pad tumor growth and prevents metastatic breast cancer osteolysis in mice
    Liu, J. C.
    Jones, M.
    Schoonmaker, J.
    Mulay, S.
    Wixted, J. J.
    Bouxsein, M.
    Scadden, D. T.
    Stein, G. S.
    Mukherjee, S.
    Lian, J. B.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 42 - 43
  • [24] Nutritional supplements in combination with chemotherapy or targeted therapy reduces tumor progression in mice bearing triple-negative breast cancer
    Guo, Chih-Hung
    Hsia, Simon
    Chung, Chieh-Han
    Lin, Yi-Chun
    Shih, Min-Yi
    Chen, Pei-Chung
    Peng, Chia-Lin
    Henning, Susanne M.
    Hsu, Guoo-Shyng W.
    Li, Zhaoping
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2021, 87
  • [25] Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and invasion
    Engebraaten, O
    Hjortland, GO
    Martinsen, M
    Halvorsen, T
    Fodstad, O
    Ree, AH
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S29 - S30
  • [26] Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and invasion
    O Engebraaten
    GO Hjortland
    M Martinsen
    T Halvorsen
    Ø Fodstad
    AH Ree
    Breast Cancer Research, 7
  • [27] Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated Processes
    Manjunath, Meghana
    Ravindran, Febina
    Sharma, Shivangi
    Siddiqua, Humaira
    Raghavan, Sathees C.
    Choudhary, Bibha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [28] Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting 227Th-DOTA-p-benzyl-trastuzumab
    Heyerdahl, Helen
    Abbas, Nasir
    Brevik, Ellen Mengshoel
    Mollatt, Camilla
    Dahle, Jostein
    PLOS ONE, 2012, 7 (08):
  • [29] Treatment of mice with SKBR-3 breast cancer or SKOV-3 ovarian cancer xenografts with low dose rate alpha-particle-emitting 227Th-trastuzumab
    Abbas, Nasir
    Bruland, Oyvind
    Hjelmerud, Anne
    Borrebaek, Jorgen
    Larsen, Aasmund
    Larsen, Roy
    Dahle, Jostein
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [30] Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation
    Saptarshi Sinha
    Subarno Paul
    Sushree Subhadra Acharya
    Chinmay Das
    Somya Ranjan Dash
    Subhasmita Bhal
    Rajalaxmi Pradhan
    Biswajit Das
    Chanakya Nath Kundu
    Medical Oncology, 41
1234